RAP1B and renal cell carcinoma: In addition, miR-28-5p acted as a TS-miRNA in renal cell carcinoma by directly repressing the expression of RAP1B [3] and in B-cell lymphoma by directly inhibiting BAG1 expression, a gene involved in the MAP-kinase pathway regulation [5].